Floatz logo

714 assets in Colorectal Cancer

Therapeutic assets addressing Colorectal Cancer, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
tqb2618
Colorectal Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.P1C (36)
Trop2-Car-Nk Cells
Colorectal Cancer
M.D. Anderson Cancer CenterP1C (36)
Tumor Antigen Loaded Autologous Dendritic Cells
Colorectal Cancer
West China HospitalP1C (36)
Ucmym802
Colorectal Cancer
UTC Therapeutics Inc.P1C (36)
Vsv-Gp128
Colorectal Cancer
Amal TherapeuticsP1C (36)
Vvd-133214
Colorectal Cancer
Vividion Therapeutics, Inc.P1C (36)
Wm-A1-3389
Colorectal Cancer
Wellmarker BioP1C (36)
zm008
Colorectal Cancer
Zumutor Biologics Inc.P1C (36)
Inulin
Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyEarly P1C (34)
Therapeutic Cancer Vaccine Genetically Modified To Express Recombinant Carcinoembryonic Antigen (Cea) Protein, Using Heat-Killed Yeast (Saccharomyces Cerevisiae) As A Vector
Colorectal Cancer
National Cancer Institute (NCI)P1/2C (34)
64Cu-EB-ss-CPT
Colorectal Cancer
Peking Union Medical College HospitalEarly P1C (33)
68ga-eb-ss-cpt
Colorectal Cancer
Peking Union Medical College HospitalEarly P1C (33)
Autologous, Engineered T Cells Targeting Tp53 R248Q
Colorectal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineEarly P1C (33)
Montelukast
Colorectal Cancer
University of South FloridaEarly P1C (33)
nk510
Colorectal Cancer
Base Therapeutics (Shanghai) Co., Ltd.Early P1C (33)
R130
Colorectal Cancer
Shanghai Yunying Medical TechnologyEarly P1C (33)
Semaglutide
Colorectal Cancer
University of ArizonaEarly P1C (33)
Vgt-309
Colorectal Cancer
Stephan RogallaEarly P1C (33)
Bifico
Colorectal Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityN/AD (30)
Colobox
Colorectal Cancer
Clinique Paris-BercyN/AD (30)
Fapi-46
Colorectal Cancer
Koo Foundation Sun Yat-Sen Cancer CenterN/AD (30)
Neoantigen-Loaded Dc Vaccine
Colorectal Cancer
The First Affiliated Hospital of Nanchang UniversityN/AD (30)
Personalized Neoantigen Peptide Vaccine
Colorectal Cancer
The First Affiliated Hospital of Nanchang UniversityN/AD (30)
Soluble Fluorescein
Colorectal Cancer
Mayo ClinicN/AD (30)
Umbellatine
Colorectal Cancer
Jing-yuan Fang, MD, Ph. DN/AD (30)
Human Interleukin 2 (Il2, T-Cell Growth Factor, Tcgf) (2-133) Variant (A1 Deleted, Pro65>Lys, Cys125>Ser), Non-Glycosylated, Produced In Escherichia Coli, Conjugated At N6 Of K65 With A Peg Derivative (30Kda)
Colorectal Cancer
SanofiP2D (28)
(±)-2-(O-Chlorophenyl)-2-(Methylamino)Cyclohexanone
Colorectal Cancer
University Tunis El ManarN/AD (26)
68ga-nota-gpa33 nanobody
Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyN/AD (26)
92.3% TO NMT 93.8% ETHANOL BY WEIGHT IN WATER
Colorectal Cancer
Rush University Medical CenterN/AD (26)
Blood, Whole
Colorectal Cancer
UNC Lineberger Comprehensive Cancer CenterN/AD (26)
Ketorolac
Colorectal Cancer
Cairo UniversityN/AD (26)
Lidocaine Hydrochloride 2% For
Colorectal Cancer
Imperial College LondonN/AD (26)
Luminomark Inj. 0.
Colorectal Cancer
Seoul St. Mary's HospitalN/AD (26)
Rifaldazine
Colorectal Cancer
Shaukat Khanum Memorial Cancer Hospital & Research CentreN/AD (26)
syh2051
Colorectal Cancer
Fujian Cancer HospitalN/AD (26)
sys6010
Colorectal Cancer
Fujian Cancer HospitalN/AD (26)
Nanrilkefusp Alfa
Colorectal Cancer
SOTIO Biotech AGP2D (25)
Sasanlimab
Colorectal Cancer
PfizerP1D (24)
Bgb-3245
Colorectal Cancer
MapKure, LLCP1D (21)
203pb-dotam
Colorectal Cancer
Hoffmann-La RocheP1NR ()
212pb-dotam
Colorectal Cancer
Hoffmann-La RocheP1NR ()
Adu-1805
Colorectal Cancer
Sairopa B.V.P1NR ()
an0025
Colorectal Cancer
Adlai Nortye Biopharma Co., Ltd.P1NR ()
Azirkitug
Colorectal Cancer
AbbVieP1NR ()
CD47/SIRPA-BLOCKING AGENT ALX148
Colorectal Cancer
University of Colorado, DenverP2NR ()
Cetuxima-Β
Colorectal Cancer
Sun Yat-sen UniversityP2/3NR ()
Showing 651 to 700 of 714 assets
PreviousPage 14 of 15Next